Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene

被引:162
作者
Hamasaki, A
Sendo, F
Nakayama, K
Ishida, N
Negishi, I
Nakayama, K
Hatakeyama, S
机构
[1] Yamagata Univ, Sch Med, Dept Immunol & Parasitol, Yamagata 9909585, Japan
[2] Kyushu Univ, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan
[3] Kyushu Univ, Lab Embryon & Genet Engn, Med Inst Bioregulat, Fukuoka 8128582, Japan
[4] Gunma Univ, Sch Med, Dept Dermatol, Maebashi, Gumma 3718511, Japan
关键词
neutrophil; apoptosis; A1; bcl-2-related gene; gene disruption;
D O I
10.1084/jem.188.11.1985
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To elucidate thr role of A1, a new member of the Bcl-2 family of apoptosis regulators active in hematopoietic cell apoptosis, we established mice lacking A1-a, a subtype of the A1 gene in mice (A1-a(-/-) mice). Spontaneous apoptosis of peripheral blood neutrophils of A1-a(-/-) mice was enhanced compared with that of tither wild-type mice or heterozygous mutants (A1-a(+/-) mice). Neutrophil apoptosis inhibition induced by lipopolysaccharide treatment in vitro or transendothelial migration in vivo observed in wild-type mice was abolished in both A1-a(-/-) and A1-a(+/-) animals. On the other hand, the extent of tumor necrosis factor alpha-induced acceleration of neutrophil apoptosis did not differ among A1-a(-/-), A1-a(+/-), and wild-type mice. The descending order of A1 mRNA expression was wild-type, A1-a(+/-), and A1-a(-/-). Taken together, these results suggest that A1 is involved in inhibition of certain types of neutrophil apoptosis.
引用
收藏
页码:1985 / 1992
页数:8
相关论文
共 51 条
  • [1] BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH
    BOISE, LH
    GONZALEZGARCIA, M
    POSTEMA, CE
    DING, LY
    LINDSTEN, T
    TURKA, LA
    MAO, XH
    NUNEZ, G
    THOMPSON, CB
    [J]. CELL, 1993, 74 (04) : 597 - 608
  • [2] BRACH MA, 1992, BLOOD, V80, P2920
  • [3] Carrio R, 1996, AM J PATHOL, V149, P2133
  • [4] COLOTTA F, 1992, BLOOD, V80, P2012
  • [5] BCL-2 PROTOONCOGENE EXPRESSION IN NORMAL AND NEOPLASTIC HUMAN MYELOID CELLS
    DELIA, D
    AIELLO, A
    SOLIGO, D
    FONTANELLA, E
    MELANI, C
    PEZZELLA, F
    PIEROTTI, MA
    DELLAPORTA, G
    [J]. BLOOD, 1992, 79 (05) : 1291 - 1298
  • [6] Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases
    Dimmeler, S
    Haendeler, J
    Nehls, M
    Zeiher, AM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) : 601 - 607
  • [7] INVOLVEMENT OF AN ICE-LIKE PROTEASE IN FAS-MEDIATED APOPTOSIS
    ENARI, M
    HUG, H
    NAGATA, S
    [J]. NATURE, 1995, 375 (6526) : 78 - 81
  • [8] IDENTIFICATION OF IMMUNOSUPPRESSANT-INDUCED APOPTOSIS IN A MURINE B-CELL LINE AND ITS PREVENTION BY BCL-X BUT NOT BCL-2
    GOTTSCHALK, AR
    BOISE, LH
    THOMPSON, CB
    QUINTANS, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) : 7350 - 7354
  • [9] INHIBITION BY BACTERIAL LIPOPOLYSACCHARIDE OF SPONTANEOUS AND TNF-ALPHA-INDUCED HUMAN NEUTROPHIL APOPTOSIS IN-VITRO
    HACHIYA, O
    TAKEDA, Y
    MIYATA, H
    WATANABE, H
    YAMASHITA, T
    SENDO, F
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 1995, 39 (09) : 715 - 723
  • [10] Multiple gene duplication and expression of mouse bcl-2-related genes, A1
    Hatakeyama, S
    Hamasaki, A
    Negishi, I
    Loh, DY
    Sendo, F
    Nakayama, K
    Nakayama, K
    [J]. INTERNATIONAL IMMUNOLOGY, 1998, 10 (05) : 631 - 637